However, Chien et al. reported that RPS19 in colorectal cancer (CRC) possibly promoted cellular apoptosis through BAX/p53 pathway, and that the level of fecal RPS19 might be used as a favorable prognostic factor for CRC patients [29]. This evidence concerns the gene TP53 and colorectal carcinoma.